The Clinical Times
The Front Page of Medicine

Latest medical news · page 56

The latest headlines across every section, pulled from official and open-access sources.

EMA (EU) · May 22, 2026

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2026

Eight new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended eight medicines for approval at its May 2026 meeting.Jascayd (nerandomilast)…, CHMP statistics Key figures from the May 2026 CHMP meeting are represented in the graphic below.  , CHMP statistics:…, Positive recommendations on new medicines, Boey INN trenibotulinumtoxinE Marketing authorisation applicant AbbVie Deutschland GmbH & Co Therapeutic indication Temporary improvement in the…, Etcamah INN camizestrant Marketing authorisation applicant Astra Zeneca Therapeutic indication…

EMA (EU) · May 22, 2026

New medicine for two types of pulmonary fibrosis

EMA has recommended granting a marketing authorisation in the European Union (EU) for Jascayd (nerandomilast) to treat adults with idiopathic pulmonary fibrosis (IPF) or…

MedlinePlus (NLM) · May 21, 2026

Hantavirus Pulmonary Syndrome

Source: Mayo Foundation for Medical Education and Research Related MedlinePlus Pages: Hantavirus Infections

MedlinePlus (NLM) · May 21, 2026

Hantavirus Infection

Source: Merck & Co., Inc. Related MedlinePlus Pages: Hantavirus Infections

ACP · May 21, 2026

ACP alarmed by abrupt firing of Preventive Service Task Force members

Statement attributable to: Jan K. Carney, MD, MPH, MACP President, American College of Physicians WASHINGTON May 21, 2026— The American College of Physicians is alarmed by the abrupt firing of two members of the United States Preventive Services Task Force (USPSTF) this week. As primary care physicians, Dr. Wong and Dr. Davis serve as important representatives for internal medicine physicians and the patients that we care for. Both physicians are highly qualified experts, and we take issue with the lack of transparency in any review that Secretary Kennedy has conducted of members of the task…

ECDC (EU) · May 21, 2026

Risk to Europe remains very low as Ebola outbreak intensifies in DRC

The risk to the general population in Europe from the current Ebola outbreak in the Democratic Republic of the Congo (DRC) and also Uganda remains very low, ECDC said in a new assessment today, while stressing that EU/EEA countries should strengthen their preparedness as the situation continues to develop.

NCQA · May 21, 2026

NCQA Receives KLAS Points of Light Award for Demonstrating the Feasibility of Bulk FHIR Exchange

We are excited to announce that NCQA and our partners, eHealth Exchange, Cambia Health Solutions and MultiCare Health System, received a 2026 KLAS Points of Light Award for a Payer/Provider Initiative. Our work to advance digital quality measurement was a cross-sector collaboration that demonstrated how Bulk FHIR® transforms quality data exchange. The Problem: Fragmented, Manual […] The post NCQA Receives KLAS Points of Light Award for Demonstrating the Feasibility of Bulk FHIR Exchange appeared first on NCQA .

PLOS Medicine · May 21, 2026

Novel symptoms associated with eclampsia could improve detection and save lives

by Alice Beardmore-Gray, Andrew Shennan Eclampsia is a life-threatening complication of pre-eclampsia, yet remains difficult to predict. In this Perspective, Alice Beardmore-Gray and Andrew Shennan highlight a recent study that identifies 10 novel prodromal symptoms of eclampsia, with potential to better predict which women are at risk and therefore reduce delays in intervention.

PLOS Medicine · May 21, 2026

U = U for all: Advancing equity in HIV prevention

by Thiago S. Torres, Paula M. Luz Suppression of HIV with antiretrovirals eliminates HIV transmission risk, summarized as Undetectable = Untransmittable (U = U). However, U = U literacy remains unevenly understood and shared, and stigmas persist. Equitable and accurate awareness of U = U requires culturally tailored interventions, improved provider education, and supportive policy environments beyond biomedical evidence alone. Suppression of HIV with antiretrovirals eliminates HIV transmission risk, summarized as Undetectable = Untransmittable (U=U). However, U=U literacy remains unevenly…

PLOS Medicine · May 21, 2026

Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies

by Jędrzej Chrzanowski, Magdalena Walicka, Jacek Burzyński, Małgorzata Zaraś, Arkadiusz Michalak, Wojciech Fendler Background Semaglutide, a glucagon-like peptide-1 receptor agonist, is widely used for the management of type 2 diabetes (T2DM). Recent case reports have raised concerns about a potential association between semaglutide use and the development of nonarteritic anterior ischemic optic neuropathy (NAION), a rare but vision-threatening condition. We aimed to evaluate whether semaglutide use is associated with an increased risk of NAION in patients with T2DM. Methods and findings We…

EMA (EU) · May 21, 2026

EMA closed on Whit Monday, 25 May

EMA’s office is closed on 25 May, to mark Whit Monday. The office reopens 08:30 on Tuesday, 26 May.The product emergency hotline is available outside working hours and on…

ECDC (EU) · May 21, 2026

Bacterial STIs reach record highs in Europe, as congenital syphilis cases nearly double

New data from the European Centre for Disease Prevention and Control (ECDC) show that sexually transmitted infections reached record levels across Europe in 2024, driven by sharp rises in gonorrhoea and syphilis, and widening gaps in testing and prevention. Targeted action is urgently needed to prevent further spread, including among women of reproductive age.

← NewerOlder →

Back to the live front page